Infoblox Offers New Tests To Assess and Validate IPv6 Implementations
Infoblox Inc. today announced IPv6 enhancements to its online DNS Advisor tool that is designed to help enterprises test the accessibility, configuration and security of their domains.
As the global supply of IPv4 addresses continues to dwindle, enterprises must be able to support the exploding number of IPv6-enabled devices, ranging from mobile phones, laptops and scanners to tablets, which will need to connect to internal networks and the Internet. Since IPv6 is a new addressing schema that impacts a myriad of network elements, automated IP address management solutions and tools, like the Infoblox DNS Advisor, will be essential to assess implementations and ensure that end users have access to domains from both IPv4 and IPv6 devices.
IPv6 and DNS expert Cricket Liu, who designed the tool, commented: “Because considerable uncertainty remains regarding the necessary steps required to successfully manage the transition from IPv4 to IPv6, some enterprises will be slow to make the move even as available IPv4 address space diminishes. Going forward, the additional IPv6 functionality in our DNS Advisor tool will help validate and instill greater confidence in enterprises’ and service providers’ IPv6 installations.”
The enhanced tool tests more than 75 facets of an organization’s DNS and IPv6 infrastructure against industry best-practice designs and architecture in six key areas:
- IPv6 Compatibility: Tests IPv6 connectivity, query responsiveness, IPv6 delegation and other compatibility-related commands
- Consistency: Searches for configuration inconsistencies that may cause longer DNS/IPv6 resolution times and compromise redundancy
- Configuration: Includes checks to ensure domains resolve properly and are reachable and resilient
- Security: Looks for security vulnerabilities
- Compliance: Tests if name servers support current protocols
At the end of the test, the tool provides an assessment report that includes an executive summary on how to mitigate any DNS and IPv6 shortcomings in the environment.
Useful Resources to Help Manage the IPv6 Transition
The online DNS Advisor tool complements Infoblox’s robust set of existing resources designed to help manage the IPv6 transition. To learn more about IPv6 enablement, myths and best practices, Infoblox offers the following resources in our IPv6 Resource Center :
- Free Trial Software : IPv6-enabled IP address management software trial download
- IPv6 Video : Cricket Liu offers clear and concise definitions and suggestions for jumpstarting your IPv6 initiatives
- IPv6 Whitepaper : “Seven Deadly IPv6 Transition Traps” outlines the mistakes to avoid throughout an IPv6 transition
- IPv6 Address Transition Tools : Details of Infoblox IPv6-ready solutions
- IPv6 Resource Center : Links to several practical IPv6 tools and a fun online challenge
For more information about Infoblox IPv6-ready products, visit: http://www.infoblox.com/en/products.html .
About Infoblox
Infoblox is an industry leading developer of network infrastructure automation and control solutions. Infoblox’s unique technologies, including the Infoblox Grid™ — a real-time, data distribution technology — increase network availability and control, while automating time-consuming manual tasks associated with network infrastructure services like domain name system (DNS) resolution, IP address management (IPAM), network change and configuration management (NCCM) and network discovery, among others. Infoblox IPv6-ready solutions are used by over 5,000 organizations worldwide, including more than one third of the Fortune 500. The company is headquartered in Santa Clara, Calif., and operates in more than 30 countries.
Contact:
Infoblox
Jennifer Jasper, 408-625-4309
jjasper@infoblox.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Transition Industries Signs Strategic Agreements for the Pacifico Mexinol Project, the Largest Standalone Ultra-Low Carbon Chemical Production Facility in the World30.6.2025 20:30:00 CEST | Press release
Pacifico Mexinol project, a 6,130 MT per day ultra-low carbon methanol production facility worth more than US$3.3b will be located near Topolobampo, Ahome, Sinaloa. Once operational in 2029, Pacifico Mexinol is poised to be the largest standalone ultra-low carbon chemical production facility in the world. Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and green hydrogen projects in North America, held a signing event for an Engineering, Procurement, and Construction (EPC) contract with the consortium of Samsung E&A Co., Ltd. (Samsung E&A), Grupo Samsung E&A Mexico, S.A. de C.V., and Techint Engineering and Construction for the Pacifico Mexinol project located in Ahome, Sinaloa, Mexico, which is contingent upon the fulfillment of customary conditions precedent and obtainment of all required approvals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630940954/en/ MAIRE group’s techn
Westinghouse and ITER Sign a $180M Contract to Advance Nuclear Fusion30.6.2025 15:45:00 CEST | Press release
The contract includes the assembly of the fusion reactor’s vacuum vessel, a key milestone which gets the project closer to replicating fusion energy on Earth Westinghouse Electric Company and ITER signed a contract for $180 million for the assembly of the vacuum vessel for the fusion reactor. This is a key milestone in the construction of the ITER reactor, leading the way toward the use of fusion as a practical future source of reliable carbon-free energy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630497810/en/ The ITER Tokamak pit with the two vacuum vessel sector modules installed. Westinghouse has participated in the fabrication of the sectors of the vacuum vessel, as part of the Fusion for Energy (F4E) Consortium with its partners Ansaldo Nucleare and Walter Tosto. Westinghouse will be responsible for completing the vacuum vessel which is ITER’s most critical component: a hermetically sealed, double-walled steel
Monetate Acquires SiteSpect to Deliver AI-Native Personalization and Testing at Enterprise Scale30.6.2025 15:00:00 CEST | Press release
Monetate’s Real-Time Personalization Unites with SiteSpect’s Zero-Flicker Testing to Optimize Digital Experiences with Unmatched Speed, Precision, and SecurityNow Global Ecommerce and Digital Experience Leaders Can Access a Best-in-Class, Enterprise-Grade Personalization, Testing, and Optimization Platform Monetate, the leading AI-driven personalization platform, today announced it has acquired SiteSpect, a leader in A/B testing, to drive next-generation digital experience optimization. This acquisition accelerates Monetate’s vision to deliver intelligent, intentional, and individualized experiences at scale, powered by agentic AI and backed by the industry’s most advanced, enterprise-grade infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630514541/en/ The combination of Monetate’s real-time personalization and SiteSpect’s zero-flicker testing will yield an industry-first solution for enterprise-grade person
SS&C Blue Prism Recognized as a Gartner® Magic Quadrant™ RPA Leader for the Seventh Consecutive Year30.6.2025 15:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that SS&C Blue Prism has been recognized as a Leader in the 2025 Gartner Magic Quadrant for Robotic Process Automation (RPA). “We’re delighted SS&C Blue Prism has been named a Leader in the Gartner Magic Quadrant for Robotic Process Automation for the seventh year running,” said Bill Stone, CEO and Chairman of SS&C Technologies. “SS&C Blue Prism combines market-leading RPA and orchestration technologies with the latest artificial intelligence so organizations can tackle more complex tasks and dynamic business processes. We’ve scaled to more than 2,700 digital workers and AI agents across our own operations, resulting in over $200 million in annual savings. With SS&C leading the charge on deployment, customers can be confident in rolling out SS&C’s automation solutions securely, effectively, and responsibly.” More than 2,800 companies worldwide leverage SS&C Blue Prism for AI-powered automation, helping organizations delive
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content130.6.2025 14:00:00 CEST | Press release
GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Approved for Intravenous or Subcutaneous Use in People Aged Two and Older with Primary Immunodeficiency1U.S. Commercialization of GAMMAGARD LIQUID ERC Projected to Begin in 2026Company Announces Future Manufacturing Discontinuation End Date for Takeda's First-Generation Low-IgA Product, A Freeze-Dried Formulation in Company’s Differentiated Immunoglobulin Portfolio of Ready-to-Use Liquids2 Takeda(TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, the only ready-to-use liquid immunoglobulin (IG) therapy with low immunoglobulin A (IgA) content, as replacement therapy for people two years of age and older with primary immunodeficiency (PI). As a ready-to-use liquid, GAMMAGARD LIQUID ERC may help ease the administratio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom